AAAAAA

   
Results: 1-19 |
Results: 19
Toward a unified theory of dendritic-cell diversity
Authors: Canque, B Gluckman, JC
Citation: B. Canque et Jc. Gluckman, Toward a unified theory of dendritic-cell diversity, TRENDS IMMU, 22(12), 2001, pp. 664-664
The maturation of dendritic cells results in postintegration inhibition ofHIV-1 replication
Authors: Bakri, Y Schiffer, C Zennou, V Charneau, P Kahn, E Benjouad, A Gluckman, JC Canque, B
Citation: Y. Bakri et al., The maturation of dendritic cells results in postintegration inhibition ofHIV-1 replication, J IMMUNOL, 166(6), 2001, pp. 3780-3788
Dendritic cells and prospects for therapeutical use
Authors: Gluckman, JC
Citation: Jc. Gluckman, Dendritic cells and prospects for therapeutical use, TRANSF CL B, 7(3), 2000, pp. 236-237
Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1 alpha
Authors: Mbemba, E Gluckman, JC Gattegno, L
Citation: E. Mbemba et al., Glycan and glycosaminoglycan binding properties of stromal cell-derived factor (SDF)-1 alpha, GLYCOBIOLOG, 10(1), 2000, pp. 21-29
Frequency of the CCR5 Delta 32 allele in the Moroccan population
Authors: Elharti, E Elaouad, R Simons, MJ Messouak-Elhachimi, Z Gluckman, JC Parmentier, M Benjouad, A
Citation: E. Elharti et al., Frequency of the CCR5 Delta 32 allele in the Moroccan population, AIDS RES H, 16(1), 2000, pp. 87-89
Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo
Authors: Schmitt, C Fohrer, H Beaudet, S Palmer, P Alpha, MJ Canque, B Gluckman, JC Dalloul, AH
Citation: C. Schmitt et al., Identification of mature and immature human thymic dendritic cells that differentially express HLA-DR and interleukin-3 receptor in vivo, J LEUK BIOL, 68(6), 2000, pp. 836-844
Soluble glycosaminoglycans do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1
Authors: Ylisastigui, L Bakri, Y Amzazi, S Gluckman, JC Benjouad, A
Citation: L. Ylisastigui et al., Soluble glycosaminoglycans do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1, VIROLOGY, 278(2), 2000, pp. 412-422
Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells
Authors: Canque, B Camus, S Dalloul, A Kahn, E Yagello, M Dezutter-Dambuyant, C Schmitt, D Schmitt, C Gluckman, JC
Citation: B. Canque et al., Characterization of dendritic cell differentiation pathways from cord blood CD34(+)CD7(+)CD45RA(+) hematopoietic progenitor cells, BLOOD, 96(12), 2000, pp. 3748-3756
CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34(+) cells
Authors: Rosenzwajg, M Tailleux, L Gluckman, JC
Citation: M. Rosenzwajg et al., CD13/N-aminopeptidase is involved in the development of dendritic cells and macrophages from cord blood CD34(+) cells, BLOOD, 95(2), 2000, pp. 453-460
Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection
Authors: Salmon-Ceron, D Excler, JL Finkielsztein, L Autran, B Gluckman, JC Sicard, D Matthews, TJ Meignier, B Valentin, C El Habib, R Blondeau, C Raux, M Moog, C Tartaglia, J Chong, P Klein, M Milcamps, B Heshmati, F Plotkin, S
Citation: D. Salmon-ceron et al., Safety and immunogenicity of a live recombinant canarypox virus expressingHIV type 1 gp120 MN tm/gag/protease LAI (ALVAC-HIV, vCP205) followed by a p24E-V3 MN synthetic peptide (CLTB-36) administered in healthy volunteers at low risk for HIV infection, AIDS RES H, 15(7), 1999, pp. 633-645
Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages (vol 14, pg 1605, 1998)
Authors: Rabehi, L Seddiki, N Benjouad, A Gluckman, JC Gattegno, L
Citation: L. Rabehi et al., Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages (vol 14, pg 1605, 1998), AIDS RES H, 15(5), 1999, pp. 493-493
Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells
Authors: Palucka, KA Taquet, N Sanchez-Chapuis, F Gluckman, JC
Citation: Ka. Palucka et al., Lipopolysaccharide can block the potential of monocytes to differentiate into dendritic cells, J LEUK BIOL, 65(2), 1999, pp. 232-240
Problems raised by the in vitro generation of dendritic cells for use in immunotherapy
Authors: Rosenzwajg, M Gluckman, JC
Citation: M. Rosenzwajg et Jc. Gluckman, Problems raised by the in vitro generation of dendritic cells for use in immunotherapy, EXP HEMATOL, 27(2), 1999, pp. 387-388
Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients
Authors: Rosenzwajg, M Fery, N Bons, V Damaj, G Gluckman, E Gluckman, JC
Citation: M. Rosenzwajg et al., Human herpes virus 8 (HHV8) serology in allogeneic bone marrow transplant recipients, BONE MAR TR, 24(4), 1999, pp. 351-354
Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein
Authors: Vita, C Drakopoulou, E Vizzavona, J Rochette, S Martin, L Menez, A Roumestand, C Yang, YS Ylisastigui, L Benjouad, A Gluckman, JC
Citation: C. Vita et al., Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein, P NAS US, 96(23), 1999, pp. 13091-13096
The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage
Authors: Canque, B Bakri, Y Camus, S Yagello, M Benjouad, A Gluckman, JC
Citation: B. Canque et al., The susceptibility to X4 and R5 human immunodeficiency virus-1 strains of dendritic cells derived in vitro from CD34(+) hematopoietic progenitor cells is primarily determined by their maturation stage, BLOOD, 93(11), 1999, pp. 3866-3875
Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages
Authors: Rabehi, L Seddiki, N Benjouad, A Gluckman, JC Gattegno, L
Citation: L. Rabehi et al., Interaction of human immunodeficiency virus type 1 envelope glycoprotein V3 loop with CCR5 and CD4 at the membrane of human primary macrophages, AIDS RES H, 14(18), 1998, pp. 1605-1615
Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2
Authors: Ylisastigui, L Amzazi, S Bakri, Y Vizzavona, J Vita, C Gluckman, JC Benjouad, A
Citation: L. Ylisastigui et al., Effect of RANTES on the infection of monocyte-derived primary macrophages by human immunodeficiency virus type 1 and type 2, BIOMED PHAR, 52(10), 1998, pp. 447-453
The inhibitory effect of RANTES on the infection of primary macrophages byR5 human immunodeficiency virus type-1 depends on the macrophage activation state
Authors: Amzazi, S Ylisastigui, L Bakri, Y Rabehi, L Gattegno, L Parmentier, M Gluckman, JC Benjouad, A
Citation: S. Amzazi et al., The inhibitory effect of RANTES on the infection of primary macrophages byR5 human immunodeficiency virus type-1 depends on the macrophage activation state, VIROLOGY, 252(1), 1998, pp. 96-105
Risultati: 1-19 |